OICR (OHS Breast Cancer Risk, Dr. P. Awadalla)

FACIT-70 | OICR (OHS Breast Cancer Risk, Dr. P. Awadalla)

December 17, 2024 – DNA methylation and breast cancer risk (Ontario Health Study)

FACIT-71 | Robarts Research Institute (3D ABUS, Dr. A. Fenster)

November 1, 2024 –

FACIT-40 | Esphera SynBio

August 14, 2024 –

FACIT-69 | Yellowbird Diagnostics Inc.

April 1, 2024 –

FACIT-68 | DTPx Therapeutics (UHN)

December 31, 2023 –

FACIT-67 | Virano Therapeutics

December 22, 2023 –

FACIT-66 | QuAccel (OICR)

May 3, 2023 –

FACIT-65 | HDAX Therapeutics

September 26, 2022 –

FACIT-64 | Hyivy Health

September 26, 2022 –

FACIT-63 | doctalk

May 19, 2022 –